Invasive Meningococcal Disease caused by Neisseria meningitidis serogroup C
Also known as: Meningococcal Disease caused by Neisseria meningitidis serogroup C / Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup C
Drug | Drug Name | Drug Description |
---|---|---|
DB10061 | Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | A conjugate vaccine used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. |
DB13890 | Meningococcal polysaccharide vaccine group C | Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and... |
DB15681 | Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen | Not Annotated |
DB10799 | Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen | Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine... |
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|